The present invention relates to new polynucleotides derived from the nucleotide sequence of the IFN.alpha.-5 gene comprising new SNPs, and new polypeptides derived from the natural wild-type IFN.alpha.-5 protein comprising at least one mutation caused by at least one SNP of the invention as well as their therapeutic uses.

 
Web www.patentalert.com

< Bioactive peptides, uses thereof and process for the production of same

> Extracts from sophora species, method for producing the same and their use
~ 00425